- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2308
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,308 companies
Microba Life Sciences
Market Cap: AU$73.9m
Provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.
MAP
AU$0.17
7D
-5.7%
1Y
-17.5%
ImmuCell
Market Cap: US$47.3m
An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
ICCC
US$5.27
7D
0.6%
1Y
11.2%
Sernova Biotherapeutics
Market Cap: CA$65.7m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.20
7D
0%
1Y
-37.5%
Recce Pharmaceuticals
Market Cap: AU$72.4m
Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States.
RCE
AU$0.29
7D
-3.3%
1Y
-53.2%
Opus Genetics
Market Cap: US$46.4m
A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs).
IRD
US$1.02
7D
7.4%
1Y
-43.0%
Camp4 Therapeutics
Market Cap: US$46.4m
A clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.
CAMP
US$2.30
7D
9.5%
1Y
n/a
Radius Residential Care
Market Cap: NZ$78.3m
Provides health and aged care services for elderly and disabled people in New Zealand.
RAD
NZ$0.28
7D
0%
1Y
123.6%
Apiam Animal Health
Market Cap: AU$71.7m
A vertically integrated animal health company, provides veterinary products and services to production and companion animals, and equine in Australia.
AHX
AU$0.40
7D
0%
1Y
11.1%
Celularity
Market Cap: US$45.9m
A clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases.
CELU
US$2.04
7D
34.2%
1Y
-35.0%
Mural Oncology
Market Cap: US$45.7m
Operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.
MURA
US$2.65
7D
0.4%
1Y
-29.7%
Karyopharm Therapeutics
Market Cap: US$45.6m
A commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.
KPTI
US$5.32
7D
-13.5%
1Y
-68.9%
Maverick Lifestyle
Market Cap: US$45.4m
Engages in the manufacture, branding, marketing, distribution, and sale of products infused with hemp-derived cannabinoids in the United States.
MVRK
US$4.75
7D
n/a
1Y
n/a
PMV Pharmaceuticals
Market Cap: US$45.0m
A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.
PMVP
US$0.87
7D
0.2%
1Y
-60.8%
Basel Medical Group
Market Cap: US$44.5m
Provides healthcare services in Singapore.
BMGL
US$2.37
7D
-49.6%
1Y
n/a
Xilio Therapeutics
Market Cap: US$44.5m
A clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies.
XLO
US$0.86
7D
17.6%
1Y
-31.2%
Vitasora Health
Market Cap: AU$69.3m
An e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States.
VHL
AU$0.042
7D
-6.7%
1Y
40.0%
Adverum Biotechnologies
Market Cap: US$44.2m
A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.
ADVM
US$2.12
7D
-22.0%
1Y
-74.4%
Neurizon Therapeutics
Market Cap: AU$68.9m
A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally.
NUZ
AU$0.15
7D
11.1%
1Y
-18.9%
Actinogen Medical
Market Cap: AU$68.9m
A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.
ACW
AU$0.022
7D
-18.5%
1Y
-15.4%
House of Jane
Market Cap: US$44.1m
Provides lifestyle therapy products.
HOJI
US$4.00
7D
0%
1Y
n/a
Biodesix
Market Cap: US$44.0m
Operates as a diagnostic solutions company.
BDSX
US$0.30
7D
-16.2%
1Y
-80.8%
BioNxt Solutions
Market Cap: CA$61.4m
Engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability.
BNXT
CA$0.53
7D
9.3%
1Y
39.5%
Vicarious Surgical
Market Cap: US$43.8m
Develops and sells single-port surgical robot in the United States.
RBOT
US$7.38
7D
-16.8%
1Y
-35.5%
TELA Bio
Market Cap: US$43.5m
A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.
TELA
US$1.10
7D
8.9%
1Y
-82.5%
RenovoRx
Market Cap: US$43.1m
A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$1.18
7D
11.3%
1Y
-15.7%
Medical Developments International
Market Cap: AU$67.0m
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.57
7D
-7.3%
1Y
43.8%
MedMira
Market Cap: CA$59.6m
A biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally.
MIR
CA$0.085
7D
0%
1Y
-10.5%
Mersana Therapeutics
Market Cap: US$42.4m
A clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs.
MRSN
US$0.34
7D
-5.7%
1Y
-87.7%
Avalo Therapeutics
Market Cap: US$42.3m
A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.
AVTX
US$3.91
7D
-2.3%
1Y
-64.8%
Anebulo Pharmaceuticals
Market Cap: US$41.9m
A clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.
ANEB
US$1.02
7D
4.1%
1Y
-52.6%
Nowtransit
Market Cap: US$41.6m
Distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses.
NOTR
US$1.00
7D
0%
1Y
n/a
Connect Biopharma Holdings
Market Cap: US$41.6m
A clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases.
CNTB
US$0.75
7D
-6.4%
1Y
-55.0%
Kronos Bio
Market Cap: US$41.5m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics to treat cancer and other serious diseases in the United States.
KRON
US$0.68
7D
-8.0%
1Y
-34.5%
ImpediMed
Market Cap: AU$64.8m
A medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe.
IPD
AU$0.034
7D
0%
1Y
-62.2%
VolitionRx
Market Cap: US$41.5m
A multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally.
VNRX
US$0.43
7D
-13.1%
1Y
-42.5%
NRx Pharmaceuticals
Market Cap: US$41.4m
A clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain.
NRXP
US$2.45
7D
17.8%
1Y
-39.7%